Lory Hage
Papers
1
Total Citations
7
H-Index
1
About
Lory Hage is a dedicated clinical researcher whose work centers on urologic oncology and rare genitourinary pathologies. Her most-cited paper, a 2024 systematic review on inflammatory myofibroblastic tumor (IMT) of the urinary bladder, exemplifies her commitment to addressing knowledge gaps in uncommon diseases. By systematically analyzing clinical presentations and comparing management strategies for this intermediate-grade lesion—which frequently recurs but rarely metastasizes—Hage provides crucial guidance where none previously existed. This work, already garnering 7 citations shortly after publication, fills a void in urologic literature by synthesizing evidence to inform treatment decisions for a condition lacking formal clinical guidelines. Her research demonstrates a keen ability to tackle challenging diagnostic and therapeutic dilemmas, offering clarity for clinicians navigating rare bladder tumors. Hage’s contributions are particularly valuable for urologists and oncologists seeking evidence-based approaches to managing these complex cases. Through her systematic methodology and focus on understudied pathologies, she is establishing herself as a thoughtful voice in urologic oncology, bridging the gap between rare disease presentation and practical clinical management.
Research Focus
Key Achievements
Top Papers
- 1